Aside from mediating the neuroinflammatory pathways, as well as the Sirt1/NF-κB pathway, Isorhamnetin was shown to have antioxidant properties that are useful in counterbalancing oxidative stress, a recurrent hallmark of neurodegenerative diseases and mood disorders [65, 66]. The gene discussed is SIRT1; the disease is mood disorder.